FELLOWS DAVID A 4
4 · Terns Pharmaceuticals, Inc. · Filed Feb 3, 2025
Insider Transaction Report
Form 4
FELLOWS DAVID A
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-01+18,650→ 18,650 totalExercise: $4.46Exp: 2035-01-31→ Common Stock (18,650 underlying)
Footnotes (2)
- [F1]This option was issued pursuant to the Issuer's Non-Employee Director Compensation Policy, under which the Reporting Person elected to receive this option in lieu of the Reporting Person's cash retainer fee of $70,000 for 2025.
- [F2]The option will vest as to 1/12th of the total shares subject thereto on each monthly anniversary measured from January 1, 2025, such that 100% of the shares subject to the option will be fully vested on January 1, 2026.